 | • レポートコード：MRC2303M092 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料によると、世界の産業医学市場規模が、予測期間中（2022年〜2027年）に年平均成長率6.25%で拡大すると予測されています。本書は、産業医学の世界市場にフォーカスし、最新動向と今後の市場性などをまとめており、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別（化学中毒、皮膚疾患、筋骨格障害、呼吸器疾患、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などが掲載されています。また、Amgen Inc、AstraZeneca、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Johnson & Johnson、Nestle (Galderma)、Novartis AG、Pfizer Inc.、Sanofi、Abbott Laboratoriesなど、主要企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の産業医学市場規模：用途別 - 化学品中毒における市場規模 - 皮膚疾患における市場規模 - 筋骨格障害における市場規模 - 呼吸器疾患における市場規模 - その他における市場規模 ・世界の産業医学市場規模：地域別 - 北米の産業医学市場規模 アメリカの産業医学市場規模 カナダの産業医学市場規模 メキシコの産業医学市場規模 … - ヨーロッパの産業医学市場規模 イギリスの産業医学市場規模 フランスの産業医学市場規模 ドイツの産業医学市場規模 … - アジア太平洋の産業医学市場規模 中国の産業医学市場規模 インドの産業医学市場規模 日本の産業医学市場規模 … - 南米/中東の産業医学市場規模 ブラジルの産業医学市場規模 アルゼンチンの産業医学市場規模 南アフリカの産業医学市場規模 … - その他地域の産業医学市場規模 ・競争状況 ・市場機会・将来の動向 |
The occupational medicines market is expected to register a CAGR of 6.25% over the forecast period (2022-2027).
While the sudden outbreak of the COVID-19 pandemic has impacted most of the business sectors negatively, the strict lockdowns and shutdowns across global industry sectors have led to reduced occupational injuries and fatalities. The manufacturing and production industries and construction sites remained closed, following strict regulations. This trend led to fewer fatalities and occupational injuries. However, the pandemic’s effect on the working population’s psychology had a drastic impact. The other health conditions such as work-related backache and stress have increased. These work-related illnesses increased by the time pandemic was at its peak. As per the study published in January 2022 titled ‘The Role of Occupational Medicine in the Response to the Coronavirus Outbreak: the Tunisian Occupational Health and Safety Institute´s experience’, the TOSHI, in collaboration with the Directorate of Medical Inspection and Occupational Safety (DMIOS), has drafted a generic guide and specific guides to health measures for the prevention of COVID-19 to the oriented resumption of professional activity in the public service, the call centers, the trade sector, the agro-food industry, and the public service. Hence, driving the growth of the studied market.
Occupational medicine helps in reducing the burden of healthcare expenditure. Providing proper care, diagnosis, and treatment in occupational medicine helps increase productivity. Because with the help of occupational medicine, the workers are provided proper training and assistance for preventing and treating diseases or injuries. Other major factors driving the growth of the studied market are a surge in awareness among the working population about occupational health, a favorable regulatory environment, increasing awareness programs organized by governments or non-governmental organizations (NGOs), and increasing chronic diseases among the working population.
Governments are paying significant attention to occupational health across the world. New laws and policies have been framed, or some existing policies have been renewed following the health level of all workers. For instance, in September 2020, the Indian government passed the occupational health and safety act in India to consolidate and amend the laws regulating occupational safety and health. This act will also amend the working conditions of the persons employed in an establishment and for matters connected. These government activities are focused on creating awareness among working groups regarding occupational health and safety, driving the growth of the studied market.
Moreover, rising product launches by the market players are expected to drive this market’s growth further. For instance, in June 2020, Cority Axion Health launched its new Occupational Medicine Solution ReadySet for Employee Health Services. The SaaS-based ReadySet solution allows hospitals to meet their employee health and occupational medicine needs in a single platform. This will lead to increased adoption of occupational medecine in patients, driving the market growth.
Therefore, owing to the abovementioned factors, the studied market is anticipated to grow over the forecast period.
Occupational Medicine Market Trends
Respiratory Diseases by Application Segment is Expected to Grow Over the Forecast Period
The respiratory diseases by application segment is expected to grow over the forecast period, among other segments. An increasing number of respiratory illnesses such as chronic obstructive pulmonary disease (COPD), asthma, and silicosis globally are poised to drive the growth of the studied segment.
Work-related respiratory diseases are several illnesses caused by breathing in hazardous substances that damage the lungs, such as dust, fumes, and gases. The occupational lung disease has been adding to the respiratory distress. People who work in drug manufacturing and antibiotics manufacturing factories complain about breathing issues, and work-related asthma is more prevalent among this target population. In an article published in September 2021, titled “Dealing with Respiratory Hazards in A Pharmaceutical Workplace,” it is mentioned that even though pharmaceutical factories are generally clean and well-maintained workspaces, air contamination through chemical hazards or pharmaceutical ingredients has been a significant occupational health and safety (OHS) issue within the pharma industry. This factor sometimes leads to acute (short-term) or chronic (long-term) respiratory effects among the workers. Hence, with the increasing drug development and manufacturing, the risk of occupational respiratory diseases is increasing. Hence, it is anticipated to drive the segment’s growth over the forecast period.
Furthermore, as per the Work-related asthma statistics in Great Britain published in December 2021, There were an estimated 174 new cases of occupational asthma reported by doctors participating in the SWORD (Surveillance of Work-Related & Occupational Respiratory Diseases) scheme within the Health and Occupation Reporting (THOR) network, United Kingdom. Additionally, as per United States Bureau of Labor Statistics data updated in November 2021, Employer-reported respiratory illnesses increased by nearly 4,000 percent in 2020 in the United States, which was estimated that employer-reported respiratory illness cases in 2020 increased to 428,700, which increased from 10,800 in 2019. Therefore, the work-related respiratory diseases segment is anticipated to grow over the forecast period globally.
Moreover, chronic respiratory diseases (CRDs) are diseases of the airways and other structures of the lung. These patients often require care and frequent medication to overcome breathing issues. Hence, the occupational medicine for the work-related respiratory diseases segment is anticipated to grow over the forecast period.
Therefore, owing to the abovementioned factors, the respiratory medicine segment is poised to witness growth over the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
North America will dominate the occupational medicines market over the forecast period. An increasing number of research and development (R&D) activities and investments in the sector, new product launches, and increasing chronic diseases are major factors attributed to the market’s growth in the region.
Moreover, according to the Pharmaceutical Research and Manufacturers of America data updates from September 2021, since 2000, PhRMA member companies have invested more than USD 1.1 Trillion in the search for new treatments and cures, including USD 102.3 Billion in 2021 alone. These healthcare expenditures in the country are expected to have a significant positive effect on occupational health and are anticipated to boost the growth of the studied market in the country.
In addition, in annual data provided by the United States Bureau of Labor Statistics for Employer-Reported Workplace Injuries and Illnesses, in 2020, Sprains, strains, and tears leading to tendonitis were 266,530, where 1,380 tendonitis patients were there in the United States. This number of workspace-related injuries is anticipated to drive the studied market’s growth over the country’s forecast period.
Therefore, owing to the factors mentioned above, the North American region is expected to have significant growth over the forecast period.
Occupational Medicine Market Competitor Analysis
The market for occupational medicine is competitive in nature. Due to the presence of several companies globally, the market studied is fragmented. The studied market consists of several international companies which hold most of the market shares and are well known, including Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Nestle (Galderma), Novartis AG, Pfizer Inc., Sanofi and Abbott Laboratories, among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Ability to Reduce the Burden of Healthcare Expenditure and Increase Productivity
4.2.2 Surge in Awareness, Favorable Regulatory environment and Increasing Awareness Programs Organized by Governments
4.2.3 Increasing Chronic Diseases among Working Population
4.3 Market Restraints
4.3.1 Increasing Adaptation of Artificial Intelligence (AI) and Automation across Industries
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Application
5.1.1 Chemical Poisoning
5.1.2 Skin Disorders
5.1.3 Musculoskeletal Disorders
5.1.4 Respiratory Diseases
5.1.5 Others
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amgen Inc
6.1.2 AstraZeneca
6.1.3 Bristol-Myers Squibb Company
6.1.4 Eli Lilly and Company
6.1.5 F. Hoffmann-La Roche Ltd.
6.1.6 Johnson & Johnson
6.1.7 Nestle (Galderma)
6.1.8 Novartis AG
6.1.9 Pfizer Inc.
6.1.10 Sanofi
6.1.11 Abbott Laboratories
7 MARKET OPPORTUNITIES AND FUTURE TRENDS